Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/29/2025 12:42 PDT] Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC), Down By 100% ($15.39) From $15.39 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [07/29/2025 07:11 PDT] CYCC Expected to Trade Down After Bearish Patterns Develop
• [07/25/2025 07:21 PDT] CYCC Expected to Trade Up After Bullish Patterns Develop
• [07/18/2025 21:21 PDT] Market Maker Surveillance Report. CYCC, Winning Stocks With Lowest Price Friction For Friday, July 18th 2025
• [07/18/2025 12:04 PDT] Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC), Up By 100% ($8.2) From $8.2 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [07/17/2025 07:45 PDT] CYCC Expected to Trade Up After Bullish Patterns Develop
• [07/15/2025 21:21 PDT] Market Maker Surveillance Report. CYCC, Winning Stocks With Lowest Price Friction For Tuesday, July 15th 2025
• [07/08/2025 07:17 PDT] CYCC Expected to Trade Down After Bearish Patterns Develop
• [07/07/2025 10:29 PDT] Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC), Up By 100% ($1.9) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, May 28th 2025 at a Price of $1.902.
• [07/07/2025 09:46 PDT] CYCC Expected to Trade Down After Bearish Patterns Develop
• [06/13/2025 08:01 PDT] CYCC Expected to Trade Up After Bullish Patterns Develop
• [06/12/2025 07:33 PDT] CYCC Expected to Trade Up After Bullish Patterns Develop